Camp4 Therapeutics Poration Stock Today

CAMP Stock  USD 1.59  0.07  4.22%   

Performance

Very Weak

 
Weak
 
Strong

Odds Of Distress

Below Average

 
High
 
Low
CAMP4 THERAPEUTICS is selling at 1.59 as of the 21st of July 2025; that is 4.22% down since the beginning of the trading day. The stock's last reported lowest price was 1.55. CAMP4 THERAPEUTICS has about a 33 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 22nd of April 2025 and ending today, the 21st of July 2025. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
11th of October 2024
Category
Healthcare
Classification
Health Care
CalAmp Corp., a connected intelligence company, provides leverages a data-driven solutions ecosystem to people and organizations in the United States, Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and internationally. The company was incorporated in 1981 and is headquartered in Irvine, California. The company has 20.16 M outstanding shares of which 335.27 K shares are currently shorted by private and institutional investors with about 3.48 trading days to cover. More on CAMP4 THERAPEUTICS PORATION

Moving against CAMP4 Stock

  0.74WF Woori Financial Group Earnings Call This WeekPairCorr
  0.72PFE Pfizer IncPairCorr
  0.71CGEN CompugenPairCorr
  0.7BAC-PL Bank of AmericaPairCorr
  0.69SHG Shinhan Financial Earnings Call This WeekPairCorr
  0.68KMDA KamadaPairCorr

CAMP4 Stock Highlights

President CEOJoshua MandelBrehm
Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Biotechnology, Communication Equipment, Technology (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.00790.0083
Notably Down
Slightly volatile
Gross Profit Margin0.250.32
Significantly Down
Very volatile
Total Current Liabilities9.1 M9.6 M
Notably Down
Pretty Stable
Non Current Liabilities Total5.3 M5.6 M
Notably Down
Slightly volatile
Total Assets74.4 M78.3 M
Notably Down
Pretty Stable
Total Current Assets92.1 M66.4 M
Significantly Up
Pretty Stable
Debt Levels
CAMP4 THERAPEUTICS can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand CAMP4 THERAPEUTICS's financial leverage. It provides some insight into what part of CAMP4 THERAPEUTICS's total assets is financed by creditors.
Liquidity
CAMP4 THERAPEUTICS PORATION currently holds 8.65 M in liabilities. CAMP4 THERAPEUTICS has a current ratio of 1.82, which is within standard range for the sector. Note, when we think about CAMP4 THERAPEUTICS's use of debt, we should always consider it together with its cash and equity.

Other Non Cash Items

1.74 Million
CAMP4 THERAPEUTICS PORATION (CAMP) is traded on NASDAQ Exchange in USA. It is located in One Kendall Square, Cambridge, MA, United States, 02139 and employs 55 people. CAMP4 THERAPEUTICS is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 102.82 M. CAMP4 THERAPEUTICS conducts business under Biotechnology sector and is part of Health Care industry. The entity has 20.16 M outstanding shares of which 335.27 K shares are currently shorted by private and institutional investors with about 3.48 trading days to cover. CAMP4 THERAPEUTICS PORATION currently holds about 47.72 M in cash with (45.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.29.
Check CAMP4 THERAPEUTICS Probability Of Bankruptcy
Ownership Allocation
CAMP4 THERAPEUTICS holds a total of 20.16 Million outstanding shares. Over half of CAMP4 THERAPEUTICS's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the entity is less than the current market value, you may not be able to make money on it.
Check CAMP4 Ownership Details

CAMP4 THERAPEUTICS Historical Income Statement

At this time, CAMP4 THERAPEUTICS's Total Other Income Expense Net is relatively stable compared to the past year. As of 07/21/2025, Research Development is likely to grow to about 40.8 M, while Gross Profit is likely to drop slightly above 619.4 K. View More Fundamentals

CAMP4 Stock Against Markets

CAMP4 THERAPEUTICS Corporate Management

Kelly GoldChief OfficerProfile
John PartainInterim ExperienceProfile
Erik SchulzInterim OfficerProfile
Christian HorneInterim SalesProfile
Brett JacksonSenior LogisticsProfile
Mark GaydosChief OfficerProfile

Additional Tools for CAMP4 Stock Analysis

When running CAMP4 THERAPEUTICS's price analysis, check to measure CAMP4 THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CAMP4 THERAPEUTICS is operating at the current time. Most of CAMP4 THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of CAMP4 THERAPEUTICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CAMP4 THERAPEUTICS's price. Additionally, you may evaluate how the addition of CAMP4 THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.